Treatment Centers

The Princess Margaret has developed a focus on the management of light-chain amyloidosis, a specific type of amyloidosis related to plasma cell dyscrasias. Our inter-professional team of pathologists, hematologists, surgeons and registered dietitians work together to monitor for amyloid deposits in body tissues. With some of the most comprehensive, cutting-edge chemotherapy, stem cell transplant and […]

The Amyloidosis Program at Penn Medicine is involved in the treatment and diagnosis of amyloidosis and the development of new drugs to treat the disease and its variants. Amyloidosis can have a variety of causes, and as a result, the Program brings together specialists from cardiology, nephrology, hematology-oncology, neurology, rheumatology, pulmonology and organ transplantation.  

The Oregon Health & Science University (OHSU) Knight Cancer Institute, known as one of the pioneers in personalized cancer medicine, is an international leader in research and cancer treatment. Driven by its mission to end cancer, the institute is building upon its expertise in targeted treatments to advance the early detection of cancer when the

Ochsner Health has been providing high-quality clinical and hospital patient care to the people of Louisiana, Mississippi and the Gulf South since 1942. Our healthcare family—today, comprising more than 30,000 employees and over 4,500 providers in over 90 medical specialties and subspecialties—is driven by our commitment to our mission to Serve, Heal, Lead, Educate and

We provide the expert, multidisciplinary care needed to manage all aspects of amyloidosis. Our team of experts specializes in the care of people who have amyloidosis, a complex disease that can affect the heart, kidneys, gastrointestinal tract, nervous system, and other organs. At the Amyloidosis Program, part of NYU Langone’s Perlmutter Cancer Center, we bring

The Amyloid Program at Northwestern Medicine is among the largest comprehensive amyloid programs in the United States and world. Northwestern Medicine patients have access to the latest diagnostic tests, innovative treatments and leading-edge clinical trials for the treatment of all types of amyloidosis. Due to the various types of amyloidosis, treatment options will be unique

MUSC Health, the clinical enterprise of the Medical University of South Carolina (MUSC), is dedicated to the pursuit of changing what’s possible in health care. Recognizing and treating amyloidosis requires specific expertise. At MUSC Health’s Cardiac Amyloidosis Clinic, experts from many specialties meet to discuss your case and develop your personalized treatment plan. At MUSC

The Multiple Myeloma and Amyloidosis program provides a valuable resource to patients with these conditions. They offer a comprehensive array of services and treatment options based on the specific challenges of each patient’s disease characteristics and stage. Through their various clinical trials, patients with multiple myeloma can access leading-edge, novel therapeutics. The clinical trials are

The multi-disciplinary Cardiac Amyloidosis Clinical Center at University of Pittsburgh and University of Pittsburgh Medical Center (UPMC) offers state-of-the-art diagnosis and management of patients with cardiac amyloidosis.  The Center serves a growing need for clinical care and research driven by the recent recognition of a high prevalence of cardiac amyloidosis, made possible by developments in

The Mount Sinai Health System is an integrated health care system providing exceptional medical care to local and global communities. Encompassing the Icahn School of Medicine at Mount Sinai and eight hospital campuses in the New York metropolitan area, as well as a large, regional ambulatory footprint, Mount Sinai is internationally acclaimed for its excellence